Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase.
Tai-Chung TsengTetsuya HosakaChun-Jen LiuFumitaka SuzukiChun-Ming HongHiromitsu KumadaWan-Ting YangChen-Yang HsuTung-Hung SuHung-Chih YangChen-Hua LiuPei-Jer ChenHsiu-Hsi ChenJia-Horng KaoPublished in: The American journal of gastroenterology (2022)
Serum HBcrAg level of 10,000 U/mL stratifies HCC risk in HBeAg-negative patients with indeterminate phase, which is useful for optimizing their clinical management.
Keyphrases